Evaluating the Use of 90-90-90 for HIV Policy in the Asian Context
Richard M. Grimes, Deanna E. Grimes
Asian Journal of Medicine and Health · pp. 43–48 · Published 26 Apr 2021
10.9734/ajmah/2021/v19i330312Abstract
UNAIDS recommends the 90-90-90 policy for controlling HIV infection (identify 90% of HIV cases, provide care for 90% of these, and have 90% of the treated achieve viral suppression). 90-90-90 requires an accurate measurement of HIV prevalence, which is impossible to achieve. Prevalence must be estimated. Customarily, 90-90-90 prevalence estimates are based on point estimates at the midpoint of a credible range of high and low estimates. This paper examines the effect of the high and low estimates on 90-90-90. We examined the impact on policy goal based on 90% of the point estimate, if the true prevalence were the credible range’s high or low estimate. This was calculated for 14 Asian Countries (Afghanistan, Cambodia, Indonesia, Iran, Kazakhstan, Laos Malaysia, Myanmar, Nepal, Pakistan, Philippines Thailand, Uzbekistan, Viet Nam) that UNAIDS estimated point prevalence of prevalence greater than 10,000 persons. If the low estimate for the 14 countries was the true prevalence, 11 of the countries could not achieve 90% of the point estimate because the low prevalence was less than 90% of the point estimate. The other three countries, would have to identify 97.5% to 99.0% of infected persons to achieve 90% of the point prevalence. If the true prevalence is the high estimate, twelve of the countries would have identified only 76.8% to 84.9 of the true prevalence. Afghanistan (26.0%) and Iran (40.8%) would have identified far fewer persons than the point estimate goal. Therefore 90-90-90 should be considered to be non-evaluable and should not be used for policy making.
References (5)
- 1 Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades [DOI]
- 2 UNAIDS 90–90–90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades” [DOI]
- 3 The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges [DOI]
- 4 The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it? [DOI]
- 5 Medication costs associated with early initiation of antiretroviral therapy [DOI]
Cited by 0
No indexed citations yet.
Related research
- Trends of HIV/AIDS in Southeast Asia — shares topic coverage
- Comparative Analysis of Responses to Covid 19 between Europe, Asia, America and Africa- A Literature Review of Four Nations — shares topic coverage
- Comparative National Prescriptive and Dosimetric Characteristics of Beta-Blocker Therapy in Asian Heart Failure Patients — shares topic coverage
- A Review on Brown Planthopper (Nilaparvata lugens Stål), a Major Pest of Rice in Asia and Pacific — shares topic coverage
- Kikuchi Fujimoto Disease – A Diagnostic Challenge — shares topic coverage
Article metrics
Real usage data collected on this platform.
65
Page views
0
PDF downloads
13
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.